---
figid: PMC9467758__OMCL2022-9029544.008
pmcid: PMC9467758
image_filename: OMCL2022-9029544.008.jpg
figure_link: /pmc/articles/PMC9467758/figure/fig8/
number: Figure 8
figure_title: ''
caption: CBR-5884 and olaparib synergistically inhibits the progression of EOC. (a)
  Cell viability, (b) colony formation, (c) cell apoptosis, (d) cell cycle, (e) cell
  migration, and (f) cell invasion condition of A2780, OVCAR3, and ES-2 cells after
  treatment of CBR-5884 with or without olaparib.
article_title: PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression
  via ROS/Wnt/Î²-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib.
citation: Xiaocui Zhang, et al. Oxid Med Cell Longev. 2022;2022:9029544.
year: '2022'

doi: 10.1155/2022/9029544
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
